Independent report · Healthcare

Even Healthcare: US$50 million Series B

November 7, 2026 · By Reena

Clinicians at Even Healthcare Source: Even Healthcare

Clinicians at Even Healthcare Source: Even Healthcare

Independent report content

ROUNDSeries B · US$50 million (about ₹475–485 crore) · all-equity primary · announced 19 Oct 2026
LEADSKhosla Ventures (existing investor since the 2021 seed)
CO-INVESTORSAlpha Wave Global; earlier backers include Founders Fund, 8VC, Lachy Groom and Sharrp Ventures
TOTAL RAISEDMore than US$120 million (about ₹1,160 crore) per the company
VALUATIONUS$300 million post-money per TechCrunch, attributed to Even and described as triple the level 18 months earlier. Inc42 reports that Even did not disclose a figure
REVENUE AND LOSSFY25 operating revenue ₹25–27 crore (FY24 ₹8 crore); net loss ₹83–90 crore, depending on the filing extract used
KEY METRICSAbout 250,000 members in 10 cities; more than 750,000 patient interactions since 2021; about 650 staff including around 300 full-time doctors
HOSPITALSTwo in Bengaluru (Race Course Road, 70 beds; HBR Layout). Plan: Indiranagar next, then more; company statements say four or five more within 6–18 months
CLAIMSUnplanned readmissions below 1% against an industry range of 8–15%; stays 40% shorter; more than 200 hospitalisations avoided (₹15–16 crore saved)
COMPANYEven Healthcare Pvt Ltd · founded 2020–21 by Mayank Banerjee, Matilde Giglio and Alessandro Ialongo · Bengaluru
THE ACCESS POINT Even Healthcare is a private company. The Series B was taken by Khosla Ventures and Alpha Wave Global. Individual investors can reach Even only through private secondary transactions in its shares, which are rare and are further limited by an employee ownership plan that gives equity to every full-time employee, or through venture funds that hold it. There is no listed proxy. Listed hospital groups (Apollo, Narayana, Max, Fortis, Medanta) carry the same hospital economics but not the membership model.

Executive decision summary

THE BOTTOM LINE Even Healthcare runs a subscription-based managed-care service in Bengaluru and has moved from partner hospitals to owning its own. Its two hospitals pay doctors fixed salaries plus outcome bonuses rather than fees per test or surgery. The US$50 million Series B, led by Khosla Ventures, funds the next hospitals. The company reports unplanned readmissions below 1% and hospital stays 40% shorter than usual. Filed accounts show the other side: FY25 operating revenue of ₹25–27 crore and a net loss of ₹83–90 crore. The US$300 million valuation reported by TechCrunch is about 105 times that revenue. Even laid off about 350 people in August 2026 as it shrank its insurance business, then raised new money two months later. The case rests on one idea: that owning the hospital lets Even keep the savings its care model creates. The first two hospitals say they have reached operating profit before depreciation. The group as a whole has not.
WHICH INVESTOR Even fits you IF you want exposure to Indian healthcare delivery through a venture-backed operator with top-tier backers, accept losses and a long path to profit, and can hold for 8–10 years through a fund or a negotiated secondary. Look elsewhere IF you need visible profits, disclosed ownership terms or near-term liquidity. Listed hospital groups offer profits and liquidity. Even offers a different model and a much higher price per rupee of revenue.
COMFORT FIT Even Healthcare = a health-maintenance club that bought its own hospital. Members pay a fee, the club looks after them day to day, and when they need surgery it happens in a ward the club owns and runs. Apollo / Manipal / Narayana = the large hospital chains. Scale, specialist depth and insurer contracts. They earn more when patients use more care, which is the incentive Even says it removed. Plum / Onsurity / Loop = the employer benefits brokers. They sell group health cover and care navigation but own no hospitals. CureBay / Practo = the neighbourhood clinic and booking layer. Lower cost, lower acuity, and no beds (see Report 06 on CureBay).
THE RUPEIA NUMBER 105x. The US$300 million valuation reported by TechCrunch, converted at about ₹96.5 per US$, is ₹2,895 crore. Divided by FY25 operating revenue of ₹27.2 crore, that is about 106 times. On the lower ₹25 crore figure it is about 116 times. Revenue is growing roughly threefold a year and the hospitals did not run for the whole of FY25, so the multiple will fall quickly. FY26 accounts, due by about November 2026, will show how fast.

1 CLAIM REGISTER: EVIDENCE GRADING

Every material claim in this note is graded by the strength of its published source. A = government, regulator or customer record. B = statutory filing or financial statement (including extracts). C = independent press. D = company announcement.

ClaimSourceGradeRupeia assessment
US$50 million all-equity Series B led by Khosla Ventures, with Alpha WaveTechCrunch, Inc42, YourStory (19 Oct 2026)CConsistent across all outlets. Allotment filings and the price per share are not published.
US$300 million post-money valuation, triple that of 18 months earlierTechCrunch (attributed to Even)CReported as a company statement. Inc42 says Even did not disclose its latest valuation. Rupeia treats it as reported, not confirmed by a filing.
Total funding above US$120 millionCompany statement via Inc42, TechCrunchDCompany figure. Individual rounds sum to roughly US$105–110 million before the Series B: US$5m seed, US$30m Series A, US$20m 2026 round plus other tranches.
FY25 revenue ₹27.2 crore, net loss ₹90.2 croreTechCrunch (regulatory filings)BFiling-based. A separate Inc42 extract shows ₹25 crore and ₹83 crore, probably a different line or entity scope.
FY24 revenue about ₹8 crore, net loss about ₹72 croreInc42 DatalabsBFiling extract. Rounded.
Two hospitals operating profitably before depreciation within a year of openingCo-founder Mayank Banerjee to TechCrunchDManagement statement. Site-level accounts are not published and the claim excludes depreciation, rent allocations and central costs.
Unplanned readmissions under 1% vs 8–15% for the industryCompany statement (Inc42, TechCrunch)DCompany figure for programmes run with insurers. Patient counts and risk adjustment are not published.
More than 200 hospitalisations avoided, saving ₹15–16 crore; insurers saved more than ₹50 croreCompany statement (Inc42, TechCrunch)DTwo separate savings claims with different scopes. Not additive.
About 250,000 members in 10 cities; 650 staff including about 300 doctorsTechCrunch; Inc42CCompany-supplied. A member may be a covered life under a group plan rather than a separately paying adult.
About 350 employees laid off in August 2026 (30–35% of staff)Entrackr via Inc42, Entrepreneur India, TechCrunchCReported and acknowledged by Mr Banerjee, who cited severance, extended health cover and accelerated vesting.
NABH 6th-edition accreditation for the Race Course Road hospitalCompany and trade pressDAccreditation is a facility-quality credential, not a measure of financial return.

2 COMPANY OVERVIEW & FOUNDING STORY

Even Healthcare Private Limited is a Bengaluru managed-care company. Its three founders are Mayank Banerjee (chief executive), Matilde Giglio (chief operating officer) and Alessandro Ialongo (chief technology officer). Sources date the founding to 2020, when the entity was set up, or 2021, when the product launched. Mr Banerjee and Ms Giglio had worked together on media technology in the United Kingdom and the United States, including the journalism start-up Compass News. Mr Ialongo is described in an interview as a school friend of Ms Giglio who left Google and moved to India to build Even. Ms Giglio is Italian, which is why the Italian press covered the Series B.

Even's clinical team in a hospital corridor: salaried doctors, rewarded for patient outcomes rather than procedure volume Source: Even Healthcare, Hospitals page (hospitals.even.in)
Even's clinical team in a hospital corridor: salaried doctors, rewarded for patient outcomes rather than procedure volume Source: Even Healthcare, Hospitals page (hospitals.even.in)

The first product was a membership. A member paid a monthly fee for round-the-clock access to doctors, a care manager, selected diagnostics and a 'care journey' that followed them from first symptom to hospital discharge. Hospital treatment was delivered by partner hospitals, with cashless cover through insurance partners. Early marketing described Even as 'insurance that includes primary care'. In January 2023 the company set up a medical advisory board to define its clinical protocols. Members included Dr Martin Gilbert, formerly of Boston Consulting Group, and Dr Abha Agarwal, then chief medical officer at Humboldt Park Health in Chicago.

The decisive change came in 2025. Mr Banerjee told TechCrunch that Even began to question the partner-hospital model after finding that patients had been advised to have tests or surgery that Even considered unnecessary. 'Insurers are getting a bad economic deal,' he said, and the company decided to build its own hospitals. That is the company's account of its own experience. It is not a published finding about any named hospital.

How Even makes money, in plain terms

Indian hospitals mostly earn per procedure, per test and per bed-day. A hospital that treats fewer patients for shorter stays earns less. Even argues that if the same organisation sells the membership, runs the clinics and owns the hospital, it can be paid once for keeping a person healthy. Savings from avoided admissions then stay inside the group instead of being lost to an outside hospital. Mr Banerjee told TechCrunch that most revenue now comes from patients paying for treatment, with the balance from insurer relationships, and that Even is working with insurer partners on a model that pays it for hospitalisations it helps prevent.

3 TIMELINE: 2020–2026

DateMilestone (company and press records)
2020–21Even founded in Bengaluru by Mayank Banerjee, Matilde Giglio and Alessandro Ialongo; operational launch of the membership product
Jul 2021Seed round of US$5 million led by Khosla Ventures, with Founders Fund, Lachy Groom and about a dozen angels
Jan 2023Medical advisory board formed to set clinical protocols
Aug 2024Entrackr reports a filing for about US$20 million, the first closing of what became the Series A
Oct 2024Series A of US$30 million (about ₹252 crore) led by Khosla Ventures, with Founders Fund, 8VC and Lachy Groom; funds earmarked for hospital operations
Mar 2025First employee stock-option buyback, US$500,000 at the primary round price, with no discount
May–Aug 2025First hospital, Even Hospital, Race Course Road, opens (70 beds, operating theatres and critical care). Press release dated 22 Aug 2025; some sources give May or July for the first patients
Late 2025Race Course Road hospital receives NABH 6th-edition accreditation, one of nine hospitals in Bengaluru to hold it
Jan–Mar 2026US$20 million round led by Lachy Groom and Alpha Wave Global, with Sharrp Ventures. Total raised about US$70 million. Plan for Indiranagar hospital (₹30–40 crore) announced; leadership appointments including Animesh Roy as chief executive of Even Hospitals
Jul 2026Press reports talks to raise US$50 million at about US$300 million
Aug 2026Entrackr reports about 350 layoffs (30–35% of staff) as Even scales back its insurance business; Entrackr reports an allotment of about ₹208 crore (US$22 million) in the Series B
19 Oct 2026US$50 million Series B announced; HBR Layout is the second operating hospital; membership about 250,000

4 FUNDING HISTORY & INVESTOR BEHAVIOUR FORENSICS

DateRoundAmountInvestors (as reported)Valuation reported
Jul 2021SeedUS$5mKhosla Ventures (lead), Founders Fund, Lachy Groom, about 12 angelsNot disclosed
Aug–Oct 2024Series AUS$30m (about ₹252 crore)Khosla Ventures (lead), Founders Fund, 8VC, Lachy GroomAbout US$81m (Multiples.vc estimate)
Early 2026Growth roundUS$20m (about ₹180 crore)Lachy Groom and Alpha Wave Global (leads), Sharrp Ventures, existing investorsAbout US$153m (press, ET and others)
19 Oct 2026Series BUS$50m (about ₹475–485 crore)Khosla Ventures (lead), Alpha Wave GlobalUS$300m post-money (TechCrunch, citing Even)

What the investor pattern shows

Khosla Ventures has led or joined every priced round since the seed. It led the seed in 2021, the Series A in 2024 and the Series B in 2026. Partner Jai Sajnani told TechCrunch that the early performance of the hospitals was a key reason for leading again. Vinod Khosla said the 'clinical and economic results so far' gave him conviction. Follow-on cheques from the first backer, three rounds in a row, are the strongest signal in the file.

Alpha Wave Global moved from the growth round to the Series B. A large growth-stage fund returning for a second time suggests it saw the early hospital numbers privately.

The cap table is dominated by US technology investors. Founders Fund, 8VC, Lachy Groom and Khosla have little history in Indian hospital property. That helps with long-term patience and hurts with local hospital benchmarks.

Valuation is rising faster than revenue. Press figures run from about US$81 million (2024) to about US$153 million (early 2026) to US$300 million (October 2026). On the earlier press figures the Series B step-up is 1.96 times, not the three times the company cites for 18 months. The two can both be true if the comparison dates differ. The earlier dates and terms are not published.

Employees share the upside. Even gives equity to every full-time employee on the same terms as the founders and ran a US$500,000 buyback at the full round price in March 2025. That helps retention. It also adds to the share count that outside buyers inherit.

RUPEIA CALCULATION US$50 million on a US$300 million post-money valuation implies a pre-money value of US$250 million and 16.7% dilution from the round alone, ignoring option pool changes and earlier closings. At ₹96.5 per US$, the round is about ₹482 crore and the post-money value about ₹2,895 crore. Total capital raised of 'more than US$120 million' is about ₹1,160 crore. The company has therefore raised about 40% of its latest post-money valuation.

5 FINANCIAL FORENSICS: WHAT THE FILINGS SHOW

MetricFY24FY25Change / reading
Operating revenue (TechCrunch, filings)n/a₹27.2 crore (about US$2.86m)TechCrunch converts ₹272 million
Operating revenue (Inc42 Datalabs)₹8 crore₹25 croreUp 3.1 times from a small base
Revenue, alternate extract (Entrackr, Aug 2026)₹6.24 crore₹25.43 croreAppears to use a different revenue line
Net loss (TechCrunch)About ₹72 crore₹90.2 crore (about US$9.5m)TechCrunch says nearly 25% above FY24
Net loss (Inc42 Datalabs)₹72 crore₹83 croreUp 15.3%
Loss as a multiple of revenueAbout 9x (₹72 cr / ₹8 cr)About 3.0–3.3xImproving ratio; absolute loss still rising

Two points stand out. First, the loss is large for the revenue. Even spent roughly three rupees of net loss for every rupee of revenue in FY25. Second, the revenue base is changing. FY25 mostly captures the membership and insurance business, with the first hospital only opening during that financial year or just after it. FY26 will include a full year of hospital revenue, offset by the restructuring costs of the insurance wind-down. Mr Banerjee told TechCrunch that Even 'could turn profitable within months' if it stopped spending on expansion, but it is choosing to grow. He did not give a profit date.

Illustrative membership arithmetic

The company reports about 250,000 members. Published starting prices for its plans are ₹400, ₹690 and ₹896 a month. The table shows what the headline membership could mean in gross billings. It is not a forecast and not Even's reported revenue, because a covered life is not always a separately paying adult, insurance premium is passed to an insurer, and many members joined late in the year.

Share of 250,000 members paying separatelyMonthly priceGross billings for 12 monthsCompared with FY25 revenue (₹27.2 cr)
25%₹400₹30 crore1.1x
50%₹400₹60 crore2.2x
100%₹400₹120 crore4.4x
100%₹690₹207 crore7.6x

6 BUSINESS MODEL & HOSPITAL UNIT ECONOMICS

Revenue streamWho paysWhat is publishedRupeia reading
Hospital treatmentPatients and insurersNow the largest share of revenue per Mr Banerjee. No segment split publishedMoves Even from asset-light to capital-heavy
Memberships (Even Care)Individuals and employersPlans from about ₹400, ₹690 and ₹896 a month. Realised revenue per member not disclosedFeeds patients into the hospitals; gross billings are not revenue
Insurer relationshipsInsurersCare management and cashless pathways. Pay-for-avoided-admission model under discussionThe upside case if insurers share savings
Group insurance (agency)EmployersEven's website states the company is not an insurer. Euston Insurance Advisors, a corporate agent, distributes cover. Magma provides group insuranceCommission-type income only; being scaled back
Clinics and diagnosticsMembers and patientsSix clinics as of early 2026; about 100 partner hospitalsFunnel, not profit centre

What 'profitable before depreciation' means

Mr Banerjee told TechCrunch that both hospitals reached operating profit, excluding depreciation, within a year of opening. This measures whether a ward's daily income covers its daily running costs. It leaves out the fit-out, the equipment and the group's central team. Even leases its hospital buildings on 20-year agreements and pays for the interior and the medical equipment itself. Site-level accounts, bed occupancy and revenue per occupied bed are not published.

Capital arithmetic for the new hospitals

ItemFigureSource
Series B proceedsUS$50m = about ₹482 croreCompany; Rupeia conversion
Indiranagar hospital, planned investment₹30–40 croreDigital Health News, Mar 2026
Five hospitals at ₹30–40 crore each₹150–200 croreRupeia calculation
Four hospitals (Inc42 plan) at the same cost₹120–160 croreRupeia calculation
Round left after hospital build-outAbout ₹280–360 croreRupeia calculation
FY25 net loss for scale₹83–90 croreFilings via Inc42, TechCrunch
Years of FY25-sized losses the remainder coversAbout 3–4Rupeia calculation; assumes no growth in loss

The numbers suggest the round is large enough for the build-out and several years of losses, if hospital capex is near the Indiranagar estimate. They also show that the real pressure is not the building. It is the hospital ramp: new wards run at low occupancy for months, while doctors and nurses are paid from day one. Press reports differ on the speed of the plan. YourStory and TechCrunch quote five new Bengaluru hospitals in six months. Inc42 quotes one by end-2026 and three more by end of FY27, which is four hospitals over about 17 months. The second version is the more cautious one.

7 CLINICAL MODEL & OUTCOME CLAIMS

Even says its doctors receive fixed salaries, with bonuses linked to patient-reported outcomes. Hospital managers are paid salaries and company-wide incentives, and the marketing team is told to bring in patients rather than revenue. Every employee holds equity. The company tracks recovery with standard scores, for example the Oxford Knee Score after knee replacement, and publishes the results on its website next to figures from other health systems. It also launched Even Spotlight, a dashboard of clinical and patient-reported outcomes, and uses an AI-based review of cases against protocols.

Company claimPublished comparisonRupeia reading
Unplanned readmissions below 1% in insurer-partner programmesIndustry range 8–15%Large gap. Patient numbers, time window and case mix are not published, so it cannot yet be read as a like-for-like result.
Hospital stays 40% shorterNo baseline statedShorter stays raise bed turnover but cut revenue per admission under fee-for-service insurance.
More than 200 members kept out of hospital, saving ₹15–16 croreImplied ₹7.5–8 lakh per avoided admissionA high figure per event. It implies avoided cases were expensive ones.
Insurers saved more than ₹50 croreSeparate claim reported by TechCrunchDifferent scope or period from the ₹15–16 crore figure. The two are not additive.
85–90% of members living near an Even hospital use itCo-founder to Inc42If true, it is the proof that membership feeds the hospital. Number of members in range is not disclosed.

The economic logic needs a contract to match. If an insurer pays Even a flat fee per treated episode, shorter stays and fewer readmissions reduce Even's income. If the insurer shares the savings, the same results raise it. The company says it is negotiating this second model with insurer partners. No signed pay-for-avoided-admission contract has been published.

8 CUSTOMER & CONTRACT INTELLIGENCE

Customer groupWhat is publishedGradeCommercial reading
Individual membersAbout 250,000 across 10 cities; membership tripled in a yearCLarge base for a primary-care product. Paying share not disclosed
Patients treatedMore than 750,000 interactions since 2021: consultations, tests and surgeriesCGives an average of about 3 interactions per member over the life of the product
EmployersGroup plans sold through the insurance agencyDNo employer named. The agency business is being reduced
Insurers and partner hospitalsCashless cover through insurance partners, including Magma for group insurance; about 100 partner hospitalsDInsurers are both customers and counterparties. No contract values published
Even hospitalsRace Course Road (70 beds) and HBR Layout operating; Indiranagar nextCCapacity at HBR Layout not published

Mr Banerjee told Inc42 that 85–90% of members living near a hospital choose Even for their care. If that holds as the network grows, each new hospital can be filled partly from the existing membership base rather than from advertising. That is the core of the model and the main reason to expect Even to compete well against stand-alone hospitals in Bengaluru. It is also why the plan is to deepen Bengaluru before entering other cities.

9 MARKET & COMPETITIVE ANALYSIS

PeerTypeOverlap with EvenEdge vs Even
Apollo Hospitals (listed)Hospital chain, pharmacy, diagnosticsInpatient care, insurer contractsScale: Apollo describes more than 70 hospitals nationally. Fee-for-service incentives
Manipal HospitalsHospital chain (Bengaluru-based)Direct inpatient rival in BengaluruDense specialist and tertiary network
Narayana Health (listed)Cost-focused hospital chainSame cost-discipline storyLarge Bengaluru presence and procedure volumes
Max, Fortis, Medanta (listed)North-India led chainsListed benchmarks for hospital valuationProfits and liquidity; no membership model
Plum, Onsurity, LoopEmployer benefits and navigationGroup health plans and telehealthEmployer relationships; no hospitals
Practo, CureBayDigital booking, clinicsLow-acuity consultationLower cost and wider reach; no beds
Insurer-owned networks and TPAsPayer-owned careManaged-care pathwaysControl of premium and claims

Market context

Government data published by PIB on 27 May 2026 shows out-of-pocket spending at 43.4% of total health spending in 2022–23 and government spending at 43.7%. Out-of-pocket share had fallen from 64.2% in FY14 but rose from 39.4% in FY22. India's general and standalone health insurers wrote about ₹1,17,505 crore of health premium in FY25 (ORF synthesis of IRDAI data), and IRDAI data records roughly 58.2 crore covered lives under 2.65 crore policies. These are market indicators, not an addressable market for Even, and adding them would double-count the same patient rupees.

The strategic point is simpler. Many Indian families still pay a large share of hospital bills themselves, and insurers face rising claims. A care provider that can show lower avoided costs has something to sell to both. The same trend is pulling large hospital chains into new beds. Business Standard coverage in July 2026 noted that new capacity depresses margins in the first years, which applies to Even in the same way.

10 MOAT ANALYSIS: WHAT PROTECTS EVEN, AND FOR HOW LONG

Moat sourceStrengthDurabilityComment
Aligned doctor incentivesMediumMediumHard to copy inside a chain that earns from volume, but a rival could launch a new brand with the same pay structure
Membership as a patient funnelMedium–strong3–5 years85–90% usage among nearby members, if sustained, lowers customer acquisition cost
Clinical data and outcome recordMediumUnprovenOutcome tracking could become a pricing tool with insurers, but needs independent publication
Capital from top-tier investorsStrong2–3 yearsUS$120 million+ raised; the next round depends on FY26 and FY27 results
Brand and accreditationMediumMediumNABH 6th-edition accreditation at Race Course Road is a quality signal in a trust-driven category
Local density in BengaluruWeak today, risingDepends on build-outTwo hospitals and a plan for several more; incumbents have many more beds

11 FOUNDERS' PATH

FounderRolePublished background
Mayank BanerjeeCo-founder and CEOPreviously worked with Matilde Giglio on media-technology ventures in the UK and US, including Compass News. Public voice of the company on the hospital strategy
Matilde GiglioCo-founder and COOItalian co-founder. Describes the mission as solving the medical-access problem in India. Leads operations and the hospital roll-out narrative
Alessandro IalongoCo-founder and CTOFormer Google engineer who relocated to India. Surname spelled differently in some press sources

The founders are not clinicians, which makes the medical advisory board and the senior hospital hires important. In early 2026 Even appointed Animesh Roy as chief executive of Even Hospitals, Dr Chandrika Kambam as director of Balloon Healthcare (its insurance and benefits arm), and Chandan Kumar as chief business officer. Business Today named the founders among India's 'coolest start-ups' founders in January 2024.

The founders and employees together own a meaningful share of the company. One aggregator estimated the three co-founders at about 39% before the latest round. Rupeia has no published cap table and treats this as an estimate.

12 TEAM, GOVERNANCE & PEOPLE

Headcount: about 650 people, of whom about 300 are full-time doctors (TechCrunch, Oct 2026). Before the August layoffs the workforce was about 1,000–1,050, on Inc42's 30–35% estimate for 350 roles.

Layoffs: about 350 roles were cut in August 2026 as Even scaled back insurance operations. Entrackr reported the numbers; Moneycontrol gave a range of 350–400. Mr Banerjee acknowledged it as a difficult decision and said staff received severance, extended health insurance and accelerated equity vesting.

Equity for all employees: every full-time employee gets options on the same terms as the founders, with guaranteed refresher grants. The March 2025 buyback of US$500,000 was priced at the primary round valuation without discount.

Investor representation: Khosla Ventures partner Jai Sajnani leads the relationship. Board composition is not published.

Compensation design: salaried doctors, outcome bonuses and managers who are not paid on revenue. This is unusual in Indian hospitals and the strongest cultural feature of the company.

13 POLICY AND REGULATORY SURFACE

Insurance. Even states that Even Healthcare Pvt Ltd is not registered with IRDAI as an insurer. Cover is distributed through a corporate agent and written by a partner insurer. Subscription revenue should therefore not be treated as underwritten premium.

Hospital licensing. State clinical-establishment rules, biomedical-waste authorisation, fire and building approvals and nursing and doctor staffing norms apply to each new site. The Race Course Road hospital holds NABH 6th-edition accreditation, which is voluntary but widely used by insurers when empanelling hospitals.

Insurer empanelment. Cashless access depends on each hospital being on insurers' networks and on tariff agreements. IRDAI's cashless-processing timelines affect the member experience.

Data protection. The company holds longitudinal health records for 250,000 members. India's digital personal data protection rules apply to consent and breach reporting.

Pay-for-outcome contracts. A model in which insurers pay for avoided hospitalisation needs a defined baseline, risk adjustment and a dispute process. No Indian regulator has issued a standard for this.

14 VALUATION ANALYSIS

MeasureCalculationResult
Post-money valuationUS$300m × ₹96.5₹2,895 crore
Pre-money valuationUS$250m × ₹96.5₹2,413 crore
Round dilutionUS$50m / US$300m16.7%
Value / FY25 revenue (₹27.2 crore)₹2,895 / 27.2About 106x
Value / FY25 revenue (₹25 crore)₹2,895 / 25About 116x
Value / net capital raisedUS$300m / US$120m2.5x
Step-up from early-2026 press valuationUS$300m / US$153m1.96x
Value per bed if 5 hospitals of 70 beds (indicative)₹2,895 crore / 350 bedsAbout ₹8.3 crore per bed

A simple revenue multiple is not helpful here, because FY25 revenue does not reflect the hospitals. A better question is what the business must earn for the investor to make an acceptable return. The next table works backwards from exit value.

Return the Series B investor wantsRequired equity value at exitIn ₹ crore (₹96.5)Multiple of FY25 revenue
3x on US$300m, no further dilutionUS$900m₹8,685 croreAbout 320x
3x with 25% later dilutionUS$1.2bn₹11,580 croreAbout 425x
5x with 25% later dilutionUS$2.0bn₹19,300 croreAbout 710x
RUPEIA READING At US$300 million the market is paying for a hospital group that does not yet exist. For a 3x return with no more dilution, Even must be worth about US$900 million (₹8,700 crore). To justify that on a typical listed hospital multiple, it would need a profitable multi-city network many times today's size. The valuation is a bet on the model scaling, not a reading of current earnings.

15 SCENARIO ANALYSIS: WHAT MOVES THE NEXT VALUATION

ScenarioProbability (Rupeia)What has to happenFY28 pictureValuation effect
Bull25%New hospitals reach profit in a year as the first two reportedly did; insurers sign shared-savings contracts; membership converts to hospital use at 85–90% in each new catchmentRevenue above ₹500 crore; group near break-evenSeries C at or above US$600m; strategic or PE interest
Base45%Four to six hospitals open on a slower schedule; hospital margins improve gradually; group loss narrows but persists through FY27Revenue ₹250–400 crore; loss ₹60–100 croreFlat to modest step-up; Series C in 2027–28
Bear30%Openings slip, occupancy is low, partner insurers keep fee-for-service terms, staff turnover rises after the layoffsRevenue below ₹200 crore; losses above ₹100 croreDown round or a bridge from existing investors

16 EXIT ANALYSIS

RouteLikelihood (6–8 yrs)PrecedentComment
Indian IPOMediumRainbow Children's (2022), Medanta (2022), KIMS and Aster DM listed with profitable hospital operationsNeeds consolidated profit and several mature hospitals. A 2030+ path
Sale to a listed hospital group or private-equity platformMediumLarge hospital chains regularly buy regional groupsValuation depends on site-level profit and bed ownership
Sale to an insurer or payerLow–mediumInsurers have built or bought care networks globallyPlausible if the pay-for-outcome model is proven
US or global strategic saleLowManaged-care rollups abroadEven's model is built around Indian insurance and tariffs
Secondary sale to later-stage fundsMediumCommon for Indian growth-stage companiesThe most realistic liquidity for employees and early holders

17 RISK ANALYSIS: RED FLAG LEDGER & KILL CONDITIONS

RiskSeverityEvidenceKill condition
Losses outrunning revenueHighFY25 loss ₹83–90 crore on ₹25–27 crore revenueFY26 loss above ₹120 crore with revenue under ₹70 crore
Hospital ramp-up and capexHighFive new hospitals in six months is aggressive; Inc42 gives a slower planFewer than two new hospitals open by September 2027
Site-level profit not publishedHighOnly a verbal claim of profit before depreciationGroup accounts show hospital segment losses after depreciation for two years
Insurer contracts stay fee-for-serviceMedium–highShorter stays lower revenue under flat tariffsNo shared-savings contract signed by end-FY27
Clinical quality incidentMediumRapid hospital growth with new teamsA serious regulatory or accreditation finding
Cultural strain after layoffsMediumAbout 350 people let go in August 2026; doctors and managers need retentionSenior clinical departures at the new hospitals
Valuation resetMediumAbout 106x FY25 revenueNext round priced below US$300 million
Lease and real-estate commitmentsMedium20-year hospital leasesLease obligations rise faster than revenue

18 INVESTOR CLASS ANALYSIS

For HNIs

Direct access is rare. If shares are offered in the unlisted market, ask for the price paid in the Series B and check the allotment filing at the registrar. A purchase at a premium to the US$300 million round price pays in advance for hospitals that are not yet built. Expect to hold for at least 7–10 years.

For family offices

The cleaner route is a co-investment alongside Khosla Ventures or Alpha Wave in a later round, or a commitment to a healthcare growth fund. Family offices with hospital property or healthcare operating experience can add real value on leases and site selection.

For institutions

Insurers and hospital groups are more likely strategic partners than investors. Growth-equity funds with healthcare mandates are the natural next buyers.

For NRIs

NRIs can hold unlisted Indian shares under FEMA non-debt instrument rules. Healthcare services allow automatic-route foreign investment, but insurance distribution has its own rules. Seek tax advice on capital gains for unlisted shares held more than 24 months.

19 COMFORT FIT: THE DECISION PAGE

If you want…Best fitWhyCaution
A new model for Indian hospital economicsEVEN HEALTHCAREDoctors on salary, owned hospitals, top-tier backersLosses; valuation about 106x revenue; model unproven at scale
Profitable listed hospitalsNarayana Health, Max Healthcare, MedantaProfits, disclosure and liquidityFee-for-service incentives; no membership funnel
Low-cost primary care at scaleCureBay (Report 06)Clinics and pharmacy in smaller townsDifferent customer; also loss-making
Diversified healthcare venture exposureHealthcare-focused AIFsSpread across providers and devices10–12 year lock-in

20 THE EARLY SIGNAL: EVENTS TO WATCH

WhenEventWhy it matters
Nov 2026–Jan 2027FY26 financial statements filedFirst full-year view of hospital revenue and the effect of the insurance wind-down
Q4 2026Series B allotment filingConfirms price per share and implied valuation
By end-2026Third hospital (Indiranagar) opensFirst test of the plan against the stated schedule
H1 2027Second and third new hospital announcementsShows whether the five-in-six-months plan or the slower Inc42 plan is right
2027First shared-savings contract with an insurerTurns the clinical claims into revenue
FY27 results (due late 2027)Hospital segment disclosureFully loaded hospital economics, not only profit before depreciation

21 RUPEIA FINAL INDEPENDENT VIEW

Even Healthcare has an original idea and strong early backers. It pays doctors for outcomes, ties the hospital to a membership base and has persuaded Khosla Ventures to lead three rounds. The company reports readmissions and stays that look much better than the industry's. Against that, the filed numbers show losses of ₹83–90 crore on ₹25–27 crore of revenue, a layoff of about 350 people in August 2026 and a valuation that is about 106 times last year's sales. The round gives Even enough money to open several hospitals and absorb several years of losses at the FY25 level. It does not prove that the group will be profitable.

THE RUPEIA NUMBER 106x: the US$300 million valuation (₹2,895 crore) against FY25 revenue of ₹27.2 crore. FY26 accounts will show how quickly hospital revenue closes the gap.
RUPEIA VERDICT A credible and unusual healthcare-delivery model priced for success. Suitable only for patient venture capital through funds or co-investment. Do not pay a secondary premium to the Series B price until FY26 accounts, the allotment price and some site-level hospital results are public.

Frequently asked questions

How much did Even Healthcare raise in 2026?

US$50 million in a Series B announced on 19 October 2026, led by Khosla Ventures with Alpha Wave Global. It followed a US$20 million round led by Lachy Groom and Alpha Wave earlier in the year. Total funding is more than US$120 million.

What is Even Healthcare's valuation?

TechCrunch reports US$300 million post-money, attributed to Even and described as three times its valuation 18 months earlier. Inc42 reports that the company did not disclose a valuation. That is about ₹2,895 crore at ₹96.5 per US$.

What is Even Healthcare's revenue?

FY25 operating revenue was ₹27.2 crore per TechCrunch, citing regulatory filings, or about ₹25 crore per Inc42 Datalabs. FY24 revenue was about ₹8 crore. FY26 accounts have not been published.

Is Even Healthcare profitable?

No. FY25 net loss was ₹83–90 crore depending on the filing extract. The company says its two hospitals reached operating profit before depreciation within a year of opening, but group-wide profit has not been reached and no date has been given.

Who founded Even Healthcare?

Mayank Banerjee (CEO), Matilde Giglio (COO) and Alessandro Ialongo (CTO), in 2020–21 in Bengaluru.

What does Even Healthcare do?

It sells a managed-care membership with doctors, diagnostics and cashless hospital cover, and now owns hospitals in Bengaluru where doctors are paid fixed salaries with outcome bonuses.

How many hospitals does Even have?

Two operating in Bengaluru: Race Course Road (70 beds) and HBR Layout. A third, in Indiranagar, is planned. Press reports give four or five more over the next 6–18 months.

Why did Even lay off 350 employees?

Entrackr reported in August 2026 that Even cut about 350 roles, 30–35% of staff, as it scaled back its insurance business and moved resources to hospitals. Mr Banerjee acknowledged the cuts.

Who are Even Healthcare's competitors?

Hospital chains such as Apollo, Manipal, Narayana, Max and Fortis; employer-benefit platforms such as Plum, Onsurity and Loop; and clinic and booking platforms such as Practo and CureBay.

Can I buy Even Healthcare shares?

Only through private secondary transactions, which are rare, or through funds that hold it. There is no listed route.

Source log

TechCrunch: Khosla Ventures doubles down on Even Healthcare to challenge India's hospital economics (19 Oct 2026)

Inc42: Even Healthcare raises $50 Mn to expand hospital network across Bengaluru (19 Oct 2026)

YourStory: Even Healthcare raises $50M in Series B round led by Khosla Ventures (19 Oct 2026)

DealStreetAsia: Khosla Ventures leads $50m funding in India's Even Healthcare (Oct 2026)

Entrepreneur India: Even Healthcare raises USD 50 Mn Series B (20 Oct 2026)

Inc42: Even Healthcare lays off 350 employees amid hospital-led pivot (Aug 2026)

Entrepreneur India: Even Healthcare lays off 350 employees (Aug 2026)

Entrackr: Even Healthcare raises $20 Mn led by Lachy Groom and Alpha Wave (2026)

Entrackr: Even Healthcare scoops up $30 Mn in Series A led by Khosla Ventures (Oct 2024)

Entrackr: Exclusive: Even Healthcare raises $20 Mn led by Khosla Ventures (Aug 2024)

YourStory: Even raises $5M seed round led by Khosla Ventures (Jul 2021)

YourStory: Even Healthcare secures $30M Series A led by Khosla Ventures (Oct 2024)

Medical Dialogues: Even Healthcare raises Rs 252 crore in Series A (Oct 2024)

Medical Dialogues: Even Healthcare to raise Rs 208 crore in Series B (Aug 2026)

Inc42: Khosla Ventures-backed Even Healthcare launches first ESOP buyback (11 Mar 2025)

Tribune India / BusinessWire: Even Healthcare opens its first hospital in Bengaluru (22 Aug 2025)

Digital Health News: After leadership shuffle, Even Healthcare to set up new hospital in Bengaluru (2026)

Business Today: Meet the founders of Even Healthcare (11 Jan 2024)

Kula Connect: Matilde Giglio's journey in founding Even

Wikipedia: Even Healthcare

Even Healthcare: hospitals website

Even Healthcare: company website

PIB: National Health Accounts 2022–23 (27 May 2026)

ORF: IRDAI FY25 premium and coverage analysis (21 Jan 2026)

Multiples.vc: Even revenue, valuation, funding and investors

Apollo Hospitals

Plum

DISCLAIMER This report is independent research by Rupeia Investments Co. built only from public sources as of the date shown. It is not an offer, solicitation or investment advice, and it is not a recommendation to buy or sell any security. Private-company figures are drawn from filings and media reports and may be revised. Unlisted and private-market investments are illiquid and carry a risk of total loss. Investors should take independent advice.